BioCurex, Inc.(fka BOCX)

[opportunityknocking]

Gold, you have an interesting point when you say that the abstracts are authored by Abbott. That is key. It is important that our next press release stress this point. I believe that any normal person may not put two and two together when reading this information and realize that this is basically being published on behalf of Abbott unless I am mistaken and this is explicitly mentioned in the article. If you just read the abstract and did not attend the meeting, the scientists involved may not disclose they are from Abbott and it could be misconstrued that they are part of Biocurex.
Corrorboration of the data independantly, that is what will get everyone excited.
Remember that Terry's job {our new trustworthy PR guy who is not a penny pumper} is to see us get exposure in something that will be major such as WallStreet Journal, BusinessWeek, Forbes, Barron's, CNN, or CNBC.
All of us went into this knowing that as an investment it was either a zero or something that will change health care as we know it.
What hooked me originally was the list of Who's Who on the scientific board of Biocurex. There is no way that the original doctors which discovered PSA, CLA, CEA would associate themselves with our company if they didn't realize that the likelihood of Recaf becoming a new cancer marker were very good.
NEW FIND!!!!!!
I urge all to go to a website:
http://www.tc-cancer.com/tumormarkers.html
It came out today and addresses the need for a general cancer marker which they say today is unavailable {not for long!}. They speak about AFP and quote Dr Sell "AFP is the single most discriminating laboratory test indicative of malignant disease now available."
Where did I see Dr Sell's name before? I could wrong but doesn't this bode well for Recaf? Isn't that what he was referring to?